Korro Bio, Inc. (KRRO) — Financial statements
Income statement, balance sheet, and cash flow for Korro Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 6↑181.5% | 2 | 0.00 | 0.00↓100.0% | 14 | |
| Cost of Revenue | 4 | 0.00 | 0.00 | 0.00↓100.0% | 4 | |
| Gross Profit | 2↓7.0% | 2 | 0.00 | 0.00↓100.0% | 10 | |
| Operating Expenses | ||||||
| R&D Expenses | 66↑3.0% | 64↑11.2% | 57↑35.7% | 42↓28.9% | 59 | |
| General & Administrative Expenses | 28↓7.8% | 31↑27.1% | 24↑43.1% | 17 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 13 | 0.00 | 0.00 | |
| SG&A Expenses | 28↓7.8% | 31↓16.4% | 37↑117.5% | 17↓51.9% | 35 | |
| Other Expenses | -4 | 0.00↑100.0% | -9 | 0.00 | 0.00 | |
| Operating Expenses | 89↓5.0% | 94↑11.4% | 85↑43.3% | 59↓37.4% | 94 | |
| Total Costs & Expenses | 94↓0.5% | 94↑11.4% | 85↑43.3% | 59↓39.9% | 98 | |
| Operating Results | ||||||
| Operating Income | -87↑5.0% | -92↓8.7% | -85↓43.3% | -59↑29.8% | -84 | |
| Depreciation & Amortization | 4↑20.1% | 4↓1.8% | 4↑44.6% | 3↓34.6% | 4 | |
| EBITDA | -83↑6.0% | -88↓9.2% | -81↓43.2% | -56↑29.4% | -80 | |
| EBIT | -87↑5.0% | -92↓8.7% | -85↓43.3% | -59↑29.7% | -84 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00 | 0.00↓100.0% | 0.83↑325.9% | -0.37 | |
| Interest Income | 0.00 | 0.00 | 0.00↓100.0% | 0.95↑138.5% | 0.40 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.12↓84.6% | 0.76 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.12 | |
| Other Income / Expenses | -29↓445.7% | 8↑149.9% | 3↑247.2% | 0.98↑252.5% | -0.64 | |
| Income Before Tax | -117↓39.8% | -83↓2.8% | -81↓39.9% | -58↑31.5% | -85 | |
| Income Tax Expense | 0.64↑351.8% | 0.14↑422.2% | 0.03↑170.0% | 0.01↓33.3% | 0.02 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -117↓40.3% | -84↓3.0% | -81↓39.9% | -58↑31.5% | -85 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -117↓40.3% | -84↓3.0% | -81↓39.9% | -58↑31.5% | -85 | |
| Bottom-Line Net Income | -117↓40.3% | -84↓3.0% | -81↓39.9% | -58↑31.5% | -85 | |
| EPS (Basic) | -12.48↓33.2% | -9.37↑82.4% | -53.09↑76.7% | -227.58↓4506.9% | -4.94 | |
| EPS (Diluted) | -12.48↓33.2% | -9.37↑82.3% | -53.08↑76.7% | -227.42↓4503.6% | -4.94 | |
| Weighted Average Shares | 9↑5.3% | 9↑483.4% | 2↑499.6% | 0.26↓94.3% | 4 | |
| Weighted Average Diluted Shares | 9↑5.3% | 9↑483.3% | 2↑499.3% | 0.26↓94.3% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.